nodes	percent_of_prediction	percent_of_DWPC	metapath
Halothane—GABRA3—Graves' disease	0.508	1	CbGaD
Halothane—CYP2A6—Methimazole—Graves' disease	0.112	0.316	CbGbCtD
Halothane—CYP2E1—Methimazole—Graves' disease	0.0742	0.208	CbGbCtD
Halothane—CYP2B6—Methimazole—Graves' disease	0.0732	0.205	CbGbCtD
Halothane—CYP2C9—Methimazole—Graves' disease	0.0387	0.109	CbGbCtD
Halothane—CYP2D6—Methimazole—Graves' disease	0.0354	0.0992	CbGbCtD
Halothane—CYP3A4—Methimazole—Graves' disease	0.0225	0.0631	CbGbCtD
Halothane—RHO—eye—Graves' disease	0.00405	0.108	CbGeAlD
Halothane—GLRB—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00382	0.0404	CbGpPWpGaD
Halothane—Isoflurane—GABRA3—Graves' disease	0.0037	1	CrCbGaD
Halothane—GLRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00302	0.0319	CbGpPWpGaD
Halothane—KCNJ6—GABA receptor activation—GABRA3—Graves' disease	0.0026	0.0276	CbGpPWpGaD
Halothane—GABRQ—GABA A receptor activation—GABRA3—Graves' disease	0.00252	0.0267	CbGpPWpGaD
Halothane—KCNJ3—GABA receptor activation—GABRA3—Graves' disease	0.00238	0.0252	CbGpPWpGaD
Halothane—KCNJ3—pituitary gland—Graves' disease	0.00232	0.0616	CbGeAlD
Halothane—GABRG3—GABA A receptor activation—GABRA3—Graves' disease	0.00208	0.022	CbGpPWpGaD
Halothane—GABRB1—GABA A receptor activation—GABRA3—Graves' disease	0.00205	0.0217	CbGpPWpGaD
Halothane—GNG2—pituitary gland—Graves' disease	0.00194	0.0514	CbGeAlD
Halothane—GABRA6—GABA A receptor activation—GABRA3—Graves' disease	0.00194	0.0205	CbGpPWpGaD
Halothane—GNG2—adipose tissue—Graves' disease	0.00193	0.0512	CbGeAlD
Halothane—GABRA4—GABA A receptor activation—GABRA3—Graves' disease	0.00191	0.0202	CbGpPWpGaD
Halothane—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00175	0.0185	CbGpPWpGaD
Halothane—RHO—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00172	0.0183	CbGpPWpGaD
Halothane—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.0017	0.018	CbGpPWpGaD
Halothane—GNG2—thyroid gland—Graves' disease	0.00167	0.0444	CbGeAlD
Halothane—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00164	0.0174	CbGpPWpGaD
Halothane—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.00163	0.0172	CbGpPWpGaD
Halothane—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.0016	0.0169	CbGpPWpGaD
Halothane—GABRQ—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00154	0.0164	CbGpPWpGaD
Halothane—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.0014	0.0148	CbGpPWpGaD
Halothane—KCNK2—adipose tissue—Graves' disease	0.00137	0.0365	CbGeAlD
Halothane—GABRG3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00127	0.0135	CbGpPWpGaD
Halothane—GABRB1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00125	0.0133	CbGpPWpGaD
Halothane—KCNJ6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.0012	0.0127	CbGpPWpGaD
Halothane—KCNK2—thyroid gland—Graves' disease	0.00119	0.0316	CbGeAlD
Halothane—GABRA6—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00118	0.0126	CbGpPWpGaD
Halothane—GABRA4—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00117	0.0124	CbGpPWpGaD
Halothane—GLRB—pituitary gland—Graves' disease	0.00115	0.0307	CbGeAlD
Halothane—GLRB—adipose tissue—Graves' disease	0.00115	0.0306	CbGeAlD
Halothane—GNG2—GABA receptor activation—GABRA3—Graves' disease	0.00113	0.0119	CbGpPWpGaD
Halothane—KCNJ3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00109	0.0116	CbGpPWpGaD
Halothane—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00107	0.0113	CbGpPWpGaD
Halothane—GABRG3—pituitary gland—Graves' disease	0.00104	0.0276	CbGeAlD
Halothane—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00104	0.011	CbGpPWpGaD
Halothane—KCNMA1—eye—Graves' disease	0.00101	0.0269	CbGeAlD
Halothane—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.001	0.0106	CbGpPWpGaD
Halothane—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.000997	0.0106	CbGpPWpGaD
Halothane—GLRB—thyroid gland—Graves' disease	0.000996	0.0265	CbGeAlD
Halothane—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.000979	0.0104	CbGpPWpGaD
Halothane—KCNN4—adipose tissue—Graves' disease	0.000978	0.026	CbGeAlD
Halothane—ATP5D—connective tissue—Graves' disease	0.000966	0.0257	CbGeAlD
Halothane—KCNJ6—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.0009	0.00953	CbGpPWpGaD
Halothane—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.000855	0.00906	CbGpPWpGaD
Halothane—NPSR1—G alpha (s) signalling events—TSHR—Graves' disease	0.00085	0.009	CbGpPWpGaD
Halothane—KCNN4—thyroid gland—Graves' disease	0.000847	0.0225	CbGeAlD
Halothane—GLRB—Ion channel transport—GABRA3—Graves' disease	0.000828	0.00877	CbGpPWpGaD
Halothane—KCNJ3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000823	0.00872	CbGpPWpGaD
Halothane—GABRQ—GABA receptor activation—GABRA3—Graves' disease	0.000819	0.00868	CbGpPWpGaD
Halothane—GABRB1—pituitary gland—Graves' disease	0.000804	0.0214	CbGeAlD
Halothane—ND1—thyroid gland—Graves' disease	0.000796	0.0212	CbGeAlD
Halothane—ATP2C1—Ion channel transport—GABRA3—Graves' disease	0.00077	0.00816	CbGpPWpGaD
Halothane—KCNMA1—adipose tissue—Graves' disease	0.000748	0.0199	CbGeAlD
Halothane—ATP5D—pituitary gland—Graves' disease	0.000744	0.0198	CbGeAlD
Halothane—ATP5D—adipose tissue—Graves' disease	0.000741	0.0197	CbGeAlD
Halothane—ATP2C1—pituitary gland—Graves' disease	0.000735	0.0195	CbGeAlD
Halothane—ATP2C1—adipose tissue—Graves' disease	0.000732	0.0194	CbGeAlD
Halothane—GABRA4—pituitary gland—Graves' disease	0.000725	0.0193	CbGeAlD
Halothane—GABRP—pituitary gland—Graves' disease	0.00072	0.0191	CbGeAlD
Halothane—KCNJ6—Neuronal System—GABRA3—Graves' disease	0.000689	0.0073	CbGpPWpGaD
Halothane—GABRG3—GABA receptor activation—GABRA3—Graves' disease	0.000675	0.00715	CbGpPWpGaD
Halothane—GABRB1—GABA receptor activation—GABRA3—Graves' disease	0.000664	0.00704	CbGpPWpGaD
Halothane—GLRA1—Ion channel transport—GABRA3—Graves' disease	0.000655	0.00693	CbGpPWpGaD
Halothane—KCNMA1—thyroid gland—Graves' disease	0.000647	0.0172	CbGeAlD
Halothane—GABRA3—thyroid gland—Graves' disease	0.000642	0.0171	CbGeAlD
Halothane—ATP5D—thyroid gland—Graves' disease	0.000642	0.0171	CbGeAlD
Halothane—GNG2—CXCR3-mediated signaling events—CXCL10—Graves' disease	0.000641	0.00679	CbGpPWpGaD
Halothane—GNG2—TSH signaling pathway—TSHR—Graves' disease	0.000638	0.00676	CbGpPWpGaD
Halothane—ATP2C1—thyroid gland—Graves' disease	0.000633	0.0168	CbGeAlD
Halothane—KCNJ3—Neuronal System—GABRA3—Graves' disease	0.00063	0.00668	CbGpPWpGaD
Halothane—GABRA6—GABA receptor activation—GABRA3—Graves' disease	0.000629	0.00666	CbGpPWpGaD
Halothane—GABRB3—eye—Graves' disease	0.000628	0.0167	CbGeAlD
Halothane—CYP2A6—adipose tissue—Graves' disease	0.000625	0.0166	CbGeAlD
Halothane—GABRA4—GABA receptor activation—GABRA3—Graves' disease	0.000621	0.00658	CbGpPWpGaD
Halothane—GABRG2—pituitary gland—Graves' disease	0.000607	0.0161	CbGeAlD
Halothane—GABRB3—connective tissue—Graves' disease	0.000605	0.0161	CbGeAlD
Halothane—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCGB3A2—Graves' disease	0.000582	0.00617	CbGpPWpGaD
Halothane—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.000568	0.00601	CbGpPWpGaD
Halothane—GABRA2—adipose tissue—Graves' disease	0.000552	0.0147	CbGeAlD
Halothane—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.000552	0.00584	CbGpPWpGaD
Halothane—GABRE—pituitary gland—Graves' disease	0.00055	0.0146	CbGeAlD
Halothane—GABRE—adipose tissue—Graves' disease	0.000547	0.0145	CbGeAlD
Halothane—KCNK18—Neuronal System—GABRA3—Graves' disease	0.000536	0.00568	CbGpPWpGaD
Halothane—KCNN4—Neuronal System—GABRA3—Graves' disease	0.000536	0.00568	CbGpPWpGaD
Halothane—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.000532	0.00564	CbGpPWpGaD
Halothane—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.000529	0.0056	CbGpPWpGaD
Halothane—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.000519	0.0055	CbGpPWpGaD
Halothane—GNG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000518	0.00548	CbGpPWpGaD
Halothane—GABRQ—Orphan transporters—GABRA3—Graves' disease	0.000478	0.00506	CbGpPWpGaD
Halothane—GABRE—thyroid gland—Graves' disease	0.000474	0.0126	CbGeAlD
Halothane—GABRB3—pituitary gland—Graves' disease	0.000466	0.0124	CbGeAlD
Halothane—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000454	0.00481	CbGpPWpGaD
Halothane—KCNK10—Neuronal System—GABRA3—Graves' disease	0.000437	0.00463	CbGpPWpGaD
Halothane—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000423	0.00448	CbGpPWpGaD
Halothane—KCNK2—Neuronal System—GABRA3—Graves' disease	0.000418	0.00442	CbGpPWpGaD
Halothane—GNG2—G beta:gamma signalling through PI3Kgamma—IL2RA—Graves' disease	0.000407	0.00431	CbGpPWpGaD
Halothane—KCNK9—Neuronal System—GABRA3—Graves' disease	0.000406	0.0043	CbGpPWpGaD
Halothane—KCNK3—Neuronal System—GABRA3—Graves' disease	0.000406	0.0043	CbGpPWpGaD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000405	0.00429	CbGpPWpGaD
Halothane—GABRB3—thyroid gland—Graves' disease	0.000402	0.0107	CbGeAlD
Halothane—GABRG3—Orphan transporters—GABRA3—Graves' disease	0.000393	0.00417	CbGpPWpGaD
Halothane—NPSR1—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.00039	0.00413	CbGpPWpGaD
Halothane—GNG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000389	0.00412	CbGpPWpGaD
Halothane—GABRB1—Orphan transporters—GABRA3—Graves' disease	0.000387	0.0041	CbGpPWpGaD
Halothane—GNG2—G-protein beta:gamma signalling—IL2RA—Graves' disease	0.000387	0.0041	CbGpPWpGaD
Halothane—GNG2—G alpha (s) signalling events—TSHR—Graves' disease	0.000385	0.00408	CbGpPWpGaD
Halothane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000377	0.00399	CbGpPWpGaD
Halothane—GABRA6—Orphan transporters—GABRA3—Graves' disease	0.000367	0.00388	CbGpPWpGaD
Halothane—GABRA4—Orphan transporters—GABRA3—Graves' disease	0.000362	0.00383	CbGpPWpGaD
Halothane—GABRQ—Ion channel transport—GABRA3—Graves' disease	0.000335	0.00355	CbGpPWpGaD
Halothane—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.000331	0.00351	CbGpPWpGaD
Halothane—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000322	0.00341	CbGpPWpGaD
Halothane—GRIN2A—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000318	0.00336	CbGpPWpGaD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000314	0.00333	CbGpPWpGaD
Halothane—GNG2—Thromboxane A2 receptor signaling—ICAM1—Graves' disease	0.000312	0.0033	CbGpPWpGaD
Halothane—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.00031	0.00329	CbGpPWpGaD
Halothane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00031	0.00329	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—TSHR—Graves' disease	0.000309	0.00327	CbGpPWpGaD
Halothane—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000308	0.00327	CbGpPWpGaD
Halothane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000305	0.00324	CbGpPWpGaD
Halothane—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000303	0.00321	CbGpPWpGaD
Halothane—KCNMA1—Neuronal System—GABRA3—Graves' disease	0.0003	0.00318	CbGpPWpGaD
Halothane—GNG2—Neuronal System—GABRA3—Graves' disease	0.000298	0.00316	CbGpPWpGaD
Halothane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000289	0.00306	CbGpPWpGaD
Halothane—GLRB—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000288	0.00305	CbGpPWpGaD
Halothane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000285	0.00302	CbGpPWpGaD
Halothane—GABRQ—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000283	0.003	CbGpPWpGaD
Halothane—GABRG3—Ion channel transport—GABRA3—Graves' disease	0.000276	0.00292	CbGpPWpGaD
Halothane—GABRB1—Ion channel transport—GABRA3—Graves' disease	0.000272	0.00288	CbGpPWpGaD
Halothane—ATP2C1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000268	0.00284	CbGpPWpGaD
Halothane—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000265	0.0028	CbGpPWpGaD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000262	0.00277	CbGpPWpGaD
Halothane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000261	0.00277	CbGpPWpGaD
Halothane—GABRA6—Ion channel transport—GABRA3—Graves' disease	0.000257	0.00272	CbGpPWpGaD
Halothane—CYP2E1—thyroid gland—Graves' disease	0.000256	0.00679	CbGeAlD
Halothane—RHO—G alpha (i) signalling events—CXCL10—Graves' disease	0.000255	0.0027	CbGpPWpGaD
Halothane—GABRA4—Ion channel transport—GABRA3—Graves' disease	0.000254	0.00269	CbGpPWpGaD
Halothane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000254	0.00269	CbGpPWpGaD
Halothane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000245	0.00259	CbGpPWpGaD
Halothane—GRIN2A—Neuronal System—GABRA3—Graves' disease	0.000243	0.00258	CbGpPWpGaD
Halothane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000243	0.00258	CbGpPWpGaD
Halothane—RHO—GPCR ligand binding—TSHR—Graves' disease	0.000239	0.00253	CbGpPWpGaD
Halothane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000239	0.00253	CbGpPWpGaD
Halothane—GNG2—CXCR4-mediated signaling events—HLA-DRB1—Graves' disease	0.000235	0.00249	CbGpPWpGaD
Halothane—GABRG3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000233	0.00247	CbGpPWpGaD
Halothane—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000232	0.00246	CbGpPWpGaD
Halothane—GABRB1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00023	0.00243	CbGpPWpGaD
Halothane—GLRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000228	0.00241	CbGpPWpGaD
Halothane—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000226	0.00239	CbGpPWpGaD
Halothane—GRIN2A—Alzheimers Disease—FAS—Graves' disease	0.000224	0.00237	CbGpPWpGaD
Halothane—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000218	0.00231	CbGpPWpGaD
Halothane—GABRA6—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000217	0.0023	CbGpPWpGaD
Halothane—GABRQ—Neuronal System—GABRA3—Graves' disease	0.000217	0.0023	CbGpPWpGaD
Halothane—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.000216	0.00229	CbGpPWpGaD
Halothane—GABRA4—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000215	0.00227	CbGpPWpGaD
Halothane—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000212	0.00225	CbGpPWpGaD
Halothane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000209	0.00221	CbGpPWpGaD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000203	0.00215	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—CXCL10—Graves' disease	0.000199	0.00211	CbGpPWpGaD
Halothane—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000196	0.00208	CbGpPWpGaD
Halothane—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000191	0.00202	CbGpPWpGaD
Halothane—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000186	0.00197	CbGpPWpGaD
Halothane—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000184	0.00195	CbGpPWpGaD
Halothane—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000183	0.00194	CbGpPWpGaD
Halothane—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000179	0.0019	CbGpPWpGaD
Halothane—GABRG3—Neuronal System—GABRA3—Graves' disease	0.000179	0.00189	CbGpPWpGaD
Halothane—GABRB1—Neuronal System—GABRA3—Graves' disease	0.000176	0.00186	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—TSHR—Graves' disease	0.000174	0.00185	CbGpPWpGaD
Halothane—GABRA6—Neuronal System—GABRA3—Graves' disease	0.000166	0.00176	CbGpPWpGaD
Halothane—GNG2—CXCR4-mediated signaling events—CD4—Graves' disease	0.000166	0.00175	CbGpPWpGaD
Halothane—GABRA4—Neuronal System—GABRA3—Graves' disease	0.000164	0.00174	CbGpPWpGaD
Halothane—GNG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00016	0.0017	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—TSHR—Graves' disease	0.000158	0.00168	CbGpPWpGaD
Halothane—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000157	0.00166	CbGpPWpGaD
Halothane—RHO—GPCR ligand binding—CXCL10—Graves' disease	0.000155	0.00164	CbGpPWpGaD
Halothane—GABRB2—Neuronal System—GABRA3—Graves' disease	0.00015	0.00159	CbGpPWpGaD
Halothane—GNG2—G alpha (i) signalling events—CXCL10—Graves' disease	0.000149	0.00158	CbGpPWpGaD
Halothane—GABRA5—Neuronal System—GABRA3—Graves' disease	0.000146	0.00155	CbGpPWpGaD
Halothane—GABRA2—Neuronal System—GABRA3—Graves' disease	0.000141	0.00149	CbGpPWpGaD
Halothane—GABRB3—Neuronal System—GABRA3—Graves' disease	0.00014	0.00148	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—TSHR—Graves' disease	0.00014	0.00148	CbGpPWpGaD
Halothane—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000138	0.00146	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—TSHR—Graves' disease	0.000135	0.00143	CbGpPWpGaD
Halothane—GRIN2A—Alzheimers Disease—IL1B—Graves' disease	0.000131	0.00139	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—FAS—Graves' disease	0.000131	0.00139	CbGpPWpGaD
Halothane—RHO—Disease—B3GNT2—Graves' disease	0.000125	0.00132	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—TSHR—Graves' disease	0.000123	0.0013	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—GABRA3—Graves' disease	0.00012	0.00127	CbGpPWpGaD
Halothane—GNG2—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.00012	0.00127	CbGpPWpGaD
Halothane—GABRQ—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000117	0.00124	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—CXCL10—Graves' disease	0.000113	0.00119	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—CXCL10—Graves' disease	0.000102	0.00108	CbGpPWpGaD
Halothane—ND1—Metabolism—GC—Graves' disease	0.000102	0.00108	CbGpPWpGaD
Halothane—ATP5D—Metabolism—GC—Graves' disease	0.000102	0.00108	CbGpPWpGaD
Halothane—GABRG3—Transmembrane transport of small molecules—GABRA3—Graves' disease	9.6e-05	0.00102	CbGpPWpGaD
Halothane—GRIN2A—Alzheimers Disease—TNF—Graves' disease	9.51e-05	0.00101	CbGpPWpGaD
Halothane—GABRB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	9.46e-05	0.001	CbGpPWpGaD
Halothane—GNG2—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	9.37e-05	0.000992	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—TSHR—Graves' disease	9.35e-05	0.000991	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—CXCL10—Graves' disease	9.04e-05	0.000958	CbGpPWpGaD
Halothane—GABRA6—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.95e-05	0.000948	CbGpPWpGaD
Halothane—GABRA4—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.84e-05	0.000936	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—CXCL10—Graves' disease	8.74e-05	0.000925	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—IL2RA—Graves' disease	8.61e-05	0.000912	CbGpPWpGaD
Halothane—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.08e-05	0.000856	CbGpPWpGaD
Halothane—GNG2—Metabolism—GC—Graves' disease	8.08e-05	0.000856	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—CXCL10—Graves' disease	7.93e-05	0.00084	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—TSHR—Graves' disease	7.91e-05	0.000837	CbGpPWpGaD
Halothane—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.85e-05	0.000832	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—IL2RA—Graves' disease	7.82e-05	0.000828	CbGpPWpGaD
Halothane—ND1—Metabolism—B3GNT2—Graves' disease	7.75e-05	0.000821	CbGpPWpGaD
Halothane—ATP5D—Metabolism—B3GNT2—Graves' disease	7.75e-05	0.000821	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—ICAM1—Graves' disease	7.75e-05	0.000821	CbGpPWpGaD
Halothane—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.58e-05	0.000803	CbGpPWpGaD
Halothane—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.53e-05	0.000798	CbGpPWpGaD
Halothane—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.39e-05	0.000783	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—TSHR—Graves' disease	7.25e-05	0.000768	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—TSHR—Graves' disease	7.18e-05	0.000761	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—IL2RA—Graves' disease	6.68e-05	0.000707	CbGpPWpGaD
Halothane—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	6.46e-05	0.000685	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—ICAM1—Graves' disease	6.31e-05	0.000668	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—IL2RA—Graves' disease	6.22e-05	0.000659	CbGpPWpGaD
Halothane—GNG2—Hemostasis—IL2RA—Graves' disease	6.18e-05	0.000654	CbGpPWpGaD
Halothane—GNG2—Metabolism—B3GNT2—Graves' disease	6.12e-05	0.000648	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—IL2RA—Graves' disease	6.06e-05	0.000642	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CXCL10—Graves' disease	6.04e-05	0.00064	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—IFNG—Graves' disease	5.9e-05	0.000625	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—IL1B—Graves' disease	5.26e-05	0.000557	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—CXCL10—Graves' disease	5.11e-05	0.000541	CbGpPWpGaD
Halothane—RHO—Disease—HLA-A—Graves' disease	5.06e-05	0.000536	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—ICAM1—Graves' disease	5.01e-05	0.000531	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—IFNG—Graves' disease	4.8e-05	0.000508	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CXCL10—Graves' disease	4.69e-05	0.000496	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—CXCL10—Graves' disease	4.64e-05	0.000491	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—IL2RA—Graves' disease	4.62e-05	0.000489	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—IL1B—Graves' disease	4.28e-05	0.000453	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—TSHR—Graves' disease	4.24e-05	0.000449	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—GC—Graves' disease	4.18e-05	0.000443	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—IL2RA—Graves' disease	3.9e-05	0.000414	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—TNF—Graves' disease	3.82e-05	0.000404	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—IFNG—Graves' disease	3.81e-05	0.000404	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	3.76e-05	0.000398	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—GABRA3—Graves' disease	3.7e-05	0.000392	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—IL2RA—Graves' disease	3.58e-05	0.000379	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—IL2RA—Graves' disease	3.55e-05	0.000376	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—GC—Graves' disease	3.43e-05	0.000363	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—IL1B—Graves' disease	3.4e-05	0.00036	CbGpPWpGaD
Halothane—RHO—Disease—CD4—Graves' disease	3.26e-05	0.000345	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—TNF—Graves' disease	3.11e-05	0.000329	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	2.77e-05	0.000293	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—GC—Graves' disease	2.74e-05	0.000291	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CXCL10—Graves' disease	2.74e-05	0.00029	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	2.73e-05	0.000289	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—TNF—Graves' disease	2.47e-05	0.000261	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—GC—Graves' disease	2.21e-05	0.000235	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—GC—Graves' disease	2.17e-05	0.00023	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IL2RA—Graves' disease	2.09e-05	0.000222	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—B3GNT2—Graves' disease	2.08e-05	0.00022	CbGpPWpGaD
Halothane—ALB—Metabolism—GC—Graves' disease	1.86e-05	0.000197	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—B3GNT2—Graves' disease	1.68e-05	0.000178	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—B3GNT2—Graves' disease	1.64e-05	0.000174	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—GC—Graves' disease	1.54e-05	0.000163	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—GC—Graves' disease	1.53e-05	0.000162	CbGpPWpGaD
Halothane—ALB—Hemostasis—IL2RA—Graves' disease	1.43e-05	0.000151	CbGpPWpGaD
Halothane—ALB—Metabolism—B3GNT2—Graves' disease	1.41e-05	0.00015	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—B3GNT2—Graves' disease	1.17e-05	0.000124	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—B3GNT2—Graves' disease	1.16e-05	0.000122	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—GC—Graves' disease	1.01e-05	0.000107	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—B3GNT2—Graves' disease	7.62e-06	8.08e-05	CbGpPWpGaD
